Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
O’Day Lays Out Plan For Gilead’s Continued HIV Dominance
Jan 14 2020
•
By
Joseph Haas
In San Francisco, Gilead CEO O'Day detailed how the company will maintain its dominance in HIV
More from Strategy
More from Business